Poly (ADP-ribose) polymerase (PARP), a nuclear enzyme responsible for DNA strand breaks, has been recently suggested to be crucial for apoptosis induced by a number chemotherapeutic drugs. In this study, we demonstrated that the PARP activity could be evidently elevated with a peak at 6 h when HL-60 cells were treated with a new anticancer drug GL331. Coincident with the peak of PARP activity, an apparent DNA fragmentation and apoptotic morphology were observed in cells treated with GL331. The subsequent apoptotic DNA fragmentation induced by GL331 could be completely blocked by transfecting cells with anti-sense PARP retroviral vector or by treating cells with PARP inhibitor, 3-aminobenzamide (3-AB). This blocking eect thus suggests that activation of PARP was critically involved in GL331-induced apoptosis. The fact that Bcl-2 has been found to antagonize cell death induced by a wide variety of agents, accounts for why we examined whether if Bcl-2 could antagonize GL331 eects. Interestingly, ectopic overexpression of Bcl-2 in either HL-60 or U937 cells caused in resistance towards GL331-elicited DNA fragmentation and cytotoxic eect. Additionally, Bcl-2 also attenuated the poly(ADPribosyl)ation of PARP itself as well as Histone H1 at the early period of drug treatment. However, Bcl-2 did not in¯uence the extent of DNA strand breaks induced by GL331 in either control or Bcl-2-overexpressing cells. In addition, analysis of basal PARP activity in control and several Bcl-2 overexpressing clones revealed that Bcl-2 down-regulated PARP activity under the condition without DNA damages. Above ®ndings suggest that poly(ADP-ribosyl)ation of nuclear targets is important for apoptosis induced by DNA-reactive anticancer drugs.
Introduction
Many chemotherapeutic drugs which cause DNA damage are known to induce cancer cells to undergo apoptosis (Chu, 1994; Mizumoto et al., 1994) . However, what remains obscure is the plausible mechanism by which DNA damages how to mediate intracellular signaling and subsequently, leads to apoptosis. The nuclear enzyme poly(ADP-ribose) polymerase (PARP) is a zinc ®nger nuclear protein which can bind both single-and double-stranded DNA breaks (Benjamin et al., 1980a,b) . This enzyme, which depends on the presence of DNA strand breaks for its activity (Alvarez-Gonzalez et al., 1987) , participates in a range of cellular processes which involve DNA repair (Hahn et al., 1973) , DNA replication (SimbulanRosenthal et al., 1996) , cell dierentiation (Bhatia et al., 1996) , and tumor promotion (Tseng et al., 1987) . PARP is a ubiquitous enzyme in nucleated eukaryotic cells (Ferro et al., 1984) which catalyzes the attachment of the ADP-ribose moiety of its speci®c substrate, NAD, to appropriate protein acceptors including, histones (Tanuma et al., 1985) , topoisomerase I (Ferro et al., 1984) , RNA polymerase II (Meisternst et al., 1997) , DNA polymerase a (Yoshihara et al., 1985) and primarily the enzyme itself (Ikejima et al., 1987) . The diversity among cellular substrates for PARP enzyme strongly suggests its prominently role in pivotal processes in cells.
Recently, poly(ADP-ribosyl)ation has been found to be closely related to the onset of apoptosis induced by a wide variety of agents, e.g. alkylating agents (Fritz et al., 1994) , active oxygen species (Schraufstatter et al., 1986) , topoisomerase II inhibitors, and adriamycin (Liu et al., 1989; Tanizawa et al., 1989) . Inhibiting PARP activity with its competitive inhibitors (3-aminobenzamide and benzamide) can block the induced apoptosis of these agents. This ®nding implies that increasing PARP enzyme activity markedly induces apoptosis in some cytotoxic agents under certain circumstances. As generally considered, the consumption of NAD + by PARP activation is primarily responsible for cell death in response to DNA damages (Sims et al., 1983; Tanaka et al., 1994) . The decrease in the cellular NAD + level decelerates glycolysis and other energygenerating reactions, depletes cellular ATP, disturbs cellular homeostasis and, ultimately, causes cell death. However, this energy depletion-caused cell death hypothesis contrasts with apoptosis characteristic that is an energy-requiring process (Zerez et al., 1987) . However, Yoon et al. (1996) postulated that the poly(ADP-ribosyl)ation of histone H1 by PARP leads to instability of solenoid chromatin structure as well as relaxation of internucleosomal DNA. This increases in terms of susceptibility of chromatin to cellular endonuclease that facilitates the onset of internucleosomal DNA fragmentation and apoptotic cell death.
Above observations suggest that the inappropriate poly(ADP-ribosyl)ation of intracellular proteins may mediate signal transduction and, ultimately, cause cell death owing to lethal DNA damages.
The bcl-2 proto-oncogene is rather unique among cellular genes in terms of its ability to block apoptotic deaths in multiple contexts (Jacobson et al., 1997) . Using BCL-2 in in vitro models can inhibit induction of apoptosis by diverse stimuli such as radiation (Kyprianou et al., 1997) , hyperthermia (Cuende et al., 1993) , growth factor withdrawal (Hyde et al., 1997) , glucocorticoids (Memon et al., 1995) , and multiple classes of chemotherapeutic agents (Martins et al., 1997) . The precise biochemical mechanisms by which Bcl-2 proteins in¯uence cell life and death, however, remain unclear. This is despite the fact that several theories have been advanced, including regulation of organellar Ca 2+ homeostasis (Murph et al., 1996) , reactive oxygen species production (Kane et al., 1993) , cysteine protease activation (Ibrado et al., 1996) , and mitochondrial permeability transition (PT) (Marchetti et al., 1996) . To prevent cell death induced by DNAdamaging drugs, Bcl-2 does not reduce drugs-induced damage to DNA, increase rates of DNA repair, inhibit drug-induced alterations in nucleotide pools, or change cell cycle kinetics (Fairbarn et al., 1994; Eymin et al., 1997) . Thus, Bcl-2 appears to act downstream in all of these events, perhaps preventing the damaged DNA from being translated into a signal for blocking the action associated with products of the genes involved in apoptosis.
GL331 (Genelabs, Inc., CA) is a novel podophyllotoxin-derived compound developed to replace its congener, VP-16 (Wang et al., 1990) . GL331 actively attacks tumor cells that have become resistance to VP-16 (34 and unpublished data from Genelabs, Inc.). Similar to VP-16, GL331 causes apoptosis in several culture cell lines derived from nasopharyngeal, hepatocellular, gastric, and cervical cancer types . In this study, we report on a situation in which PARP activation is critically involved in GL331-induced apoptosis in human leukemic HL-60 cells. In addition, over-expression of Bcl-2 in HL-60 cells prevents GL331-induced PARP activation, histone H1 poly(ADP-ribosyl)ation, and apoptosis. Above ®ndings suggest that Bcl-2 prevented GL331-induced apoptosis might through inhibition of poly(ADP-ribosyl)ation of histone H1 or other nuclear targets.
Results

Inhibition of PARP activity blocks GL331-induced apoptosis
Whether or not the elevation PARP activity is involved in GL331-induced apoptosis was determined. In doing so, the eect of GL331 on PARP activity in HL-60 cells was examined for various time interval. The PARP activity was determined by assaying the transfer of 32 P-labeled ADP-ribose moieties from NAD + to Figure 1 Inhibition of PARP activity by 3-aminobenzamide blocks GL331-induced apoptosis. (a) Kinetic of total intracellular PARP activity in HL-60 cells treated with GL331. Cells exposed to 0.8 mM GL331 for varying time periods as indicated, then cells were harvested and labeled by 32 P-NAD in a permeabilized cell system. After the incubation, the reaction was terminated by an addition of 1 ml of 5% trichloroacetic acid (TCA) and the acid precipitate was collected on a glass-®ber ®lter. The glass-®ber was washed twice with 5% TCA and cold ethanol, successively, and then air-dried. The radioactivity was counted. Each data point represents the mean value obtained from three independent experiments. Bars, means+s.e. *Statistically signi®cant increase in PARP activity compared with untreated control cells (P50.05). (b) Time-dependent DNA fragmentation in HL-60 cells treated with GL331. HL-60 cells were pretreated with or without 5 mM 3-AB, followed by 0.8 mM GL331 treatment or various periods of times, and DNA was extracted and analysed by agarose gel electrophoresis. (c) Flow-cytometric analysis of GL331-induced hypodiploid cells. HL-60 cells were treated with or without 5 mM 3-AB for 1 h prior to the addition of 0.8 mM GL331 for another 8 h. The hypodiploid cells was determined by DNA histogram analysis, as described in Materials and methods nuclear proteins, including PARP itself, as determined by the amount of acid radioactive precipitates on the glass-®ber ®lter. According to Figure 1a , the PARP activity was initially activated at 2 h and peaked at 4 h, respectively, after 0.8 mM GL331 treatment. Interestingly, the apparent increase in the amount of fragmented DNA was initially detected at 4 h later and became evident at 6 h after drug treatment ( Figure  1b ) coinciding with the time interval when the maximal PARP activity was observed. The observation that PARP activity initially increased before the onset of DNA fragmentation led us to investigate the possible involvement of PARP activation in the of apoptotic DNA fragmentation. As Figure 1b indicates, the internucleosomal DNA fragmentation induced by GL331 was completed inhibited by 5 mM PARP inhibitor, 3-AB. In addition, GL331-induced DNA fragmentation was also inhibited with other inhibitors, benzamide and nicotinamide (data not shown). According to¯ow cytometric analysis, 3-AB treatment also eectively retained the integrity of cells (cells with 2N and 4N DNA content) and decreased the production of hypodiploid cells (cells with 52N DNA) following GL331 treatment, as assessed by PI staining of permeabilized cells (Figure 1c , I ± IV). Given a direct evidence to prove the importance of PARP in GL331-induced apoptosis, a tetracycline (Tet) ± regulatory antisense PARP retroviral vector, pTcPARPb, was constructed and transiently transfected into the HL-60 cells. Flowcytometric analysis of PARP level in antisense PARP-transfected HL-60 cells by staining with FITC-conjugated anti-PARP antibody revealed that intracellular PARP protein was significantly decreased in those cells when Tet had been removed for 24 h, as compared to the cells in the presence of Tet (Figure 2a ). Agarose gel electrophoresis showed that GL331-induced internucleosomal DNA fragmentation was prevented in transfected cells when culturing in the absence of Tet for 24 h, but that was not inhibited in cells which were maintained with Tet ( Figure 2b ). Again,¯ow cytometric analysis con®rmed that the decrease of PARP level by antisense expression render cells more resistant to GL331-induced apoptosis (Figure 2c ).
Bcl-2 prevents GL331-induced apoptosis and poly(ADP-ribosyl)ation
The Bcl-2-transfected clone, HL-60-bcl-2, which displayed roughly threefold increase in Bcl-2 protein levels over that of parental HL-60 cells, was In the presence or absence of 1 mg/ml tetracycline (Tet) for 24 h, cells were treated with 0.8 mM GL331 for another 8 h. After treatment, cellular DNA was extracted and analysed the DNA fragmentation in agarose gel electrophoresis. (c) Flow cytometric analysis of hypodiploid cells in control (HL-60) and antisense PARPtransfected (HL-60/pTcPARPb) cells treated with 0.8 mM GL331. Cells were treated as described in Figure 2b , then cells were ®xed and subjected to PI staining for determining hypodiploid cells by¯ow cytometry. Each data point represents the mean value obtained from three independent experiments. Bars, means+s.e. *Statistically signi®cant attenuation in apoptosis compared with GL331-treated cells in the presence of Tet (P50.01) established as described elsewhere (Kuo et al., 1996) . As Figure 3a indicates HL-60-bcl-2 cells conferred a remarkable resistance to DNA fragmentation induced by GL331, compared to the parental HL-60 cells. The resistance of HL-60-bcl-2 cells to GL331 was also observed in nuclear morphologically characteristics of apoptosis, i.e., chromatin condensation and nuclear fragmentation ( Figure 3b , I ± IV). Trypan blue exclusion assay con®rmed again that Bcl-2-overexpressing cells displayed more viability than HL-60 cells during the drug treatment (data not shown). Above results indicate that Bcl-2 inhibited not only endonucleolytic activity but also abrogated apoptotic cytolysis by GL331.
The activation of PARP elicits the modi®cation of nuclear proteins by poly(ADP-ribosyl)ation. Therefore, we examined whether Bcl-2 could aect GL331-induced poly(ADP-ribosyl)ation of PARP protein itself and histone H1. The extent of poly(ADPribosyl)ation of M r 116 000 PARP protein was initially determined by activity gel assay, which assay the binding of [ and HL-60-bcl-2 cells were treated with 0.8 mM GL331 and cellular proteins were extracted and subjected to SDS ± PAGE analysis containing 0.1 mg/ml activated calf thymus DNA. The gel was washed twice with 500 ml of the renaturation buer for 2 h and then incubated twice for 1 h at room temperature in 100 ml of renaturation buer containing 0.6 M guanidine HCl. After renaturation, the gel was washed at 48C with 500 ml of the renaturation buer and then incubated with 10 ml of the labeling mixture (0.1 M Tris-HCl, pH 8.0, 10 mM MgCl 2 1 mM DTT, and 1 mM [ 32 P]NAD (50 mCi/ml) at 378C for 8 h. After extensive washing with 5% TCA, the gel was dried and subjected to autoradiography. (Lower panel), Immunoblot analysis of PARP protein in GL331-treated HL-60 and HL-60/bcl-2 cells. Total cellular proteins were performed by immunoblot analysis and con®rmed the equal amount of PARP protein in each lanes. (b) Poly(ADP-ribosyl)ation of histone H1 in HL-60 vs HL-60-bcl-2 cells treated with GL331. Histone H1 was labeled in a permeabilized cell system and extracted at various times, followed by analysis in 15% SDS ± PAGE. The 32 P-labeled histone H1 was subjected to autoradigraphy (upper panel), and stained with coomassie blue to con®rm the equal amount of histone H1 protein in each lane (Lower panel) Figure 3 Eect of GL331-induced apoptosis by Bcl-2. (a) Resistance to GL331-induced DNA fragmentation in Bcl-2-overexpressing HL-60 cells. HL-60 (H) and HL-60-bcl-2 (b) cells were treated with 0.8 mM GL-331 and harvested at various times as indicated. The cellular DNA was extracted and analysed by agarose gel electrophoresis (b) Nuclear morphological characteristics in HL-60 and HL-60-bcl-2 cells treated with GL331. HL-60 cells were treated with solvent control 0.1% DMSO (I) or with 0.8 mM GL331 (III); HL-60-bcl-2 cells were treated with 0.1% DMSO (II) or with 0.8 mM GL331 (IV), and harvested at 4 h followed by Hoechst 33258 staining. The nuclear morphological changes of cells were detected by¯uorescent microscope observation. Magni®cation: 406 upper pannel). Immunoblot analysis reveals that the amounts of PARP protein remained constant during the GL331 treatment (Figure 4a, lower panel) . This ®nding suggests that the change in poly(ADPribosyl)ation in both cells was not attributed to the alteration of protein levels.
Next, we extracted histone H1 from GL331-treated HL-60 and HL60-bcl-2 cells, and analysed its state of poly(ADP-ribosyl)ation. Again, Figure 4b (upper pannel), indicates that the poly(ADP-ribosyl)ation of histone H1 was quite apparent in HL-60 cells at 6 h following exposure to GL331. In contrast, under the same circumstances, only a background level of poly(ADP-ribosyl)ated histone H1 was detected in Bcl-2-overexpressing cells. Experimental results also indicated that the amount of histone H1 proteins extracted from both cells treated with GL331 remained unchanged (Figure 4b, down) . Cumulatively, above ®ndings suggest that a strict association emerged between the poly(ADP-ribosyl)ation of nuclear proteins, i.e., histone H1 and PARP itself, and the onset of apoptosis in response to GL331.
We further examined whether if Bcl-2 which inhibited the poly(ADP-ribosyl)ation of nuclear proteins was a restricted phenomenon for GL331 treatment. To address this issue, we treated both HL-60 cells and HL-60-bcl-2 cells with dierent anticancer drugs, which had been shown to induced PARP activation as well as apoptosis. The poly(ADPribosyl)ation of PARP protein in both cell lines was subsequently analysed. In corresponding to the data of GL331, we found that Bcl-2-overexpressing cells exhibited far less poly(ADP-ribosyl)ation of PARP than HL-60 cells in response to camptothecin, VP-16, or adriamycin ( Figure 5a ). Next, a closer examination was made of whether or not Bcl-2 attenuated GL331-induced PARP activation was not restricted to HL-60 cell context. To clarify this argument, we established a Bcl-2-overexpressing U937 clone. As Figure 5b reveals, our results consistently con®rmed that upon GL331 treatment parental U937 cells showed intensive poly(ADP-ribosyl)ation of PARP. However, in contrast, Bcl-2-overexpressing U937 cells exhibited nearly no detectable poly(ADP-ribosyl)ation of PARP.
Inverse correlation between PARP activity and Bcl-2 protein
To further con®rm the relationship between Bcl-2 and PARP, we isolated several independent Bcl-2-overexpressing HL-60 clones and analysed their expression of PARP activity in response to GL331 As Figure 6a indicates, the Bcl-2 level in each transfectant was 2 ± 3.5-fold higher than that in parental HL-60 cells. In contrast, the basal PARP activity in parental HL-60 clone was 2 ± 3.7-fold higher than that in Bcl-2 overexpressing clones (Figure 6b ). Besides, all Bcl-2 overexpressing clones were resistant to induction of PARP activity (Figure 6b ) and apoptosis ( Figure 6c ) when treating with GL331. Our results consistently demonstrated that U937-bcl-2-expressing cells exhibited a markedly lower basal PARP activity than U937 cells, as shown in Figure 5b .
Bcl-2 inhibits PARP activation not through preventing DNA damages
The fact that PARP activity is stimulated by singleand double-stranded DNA breaks (Alvarez-Gonzalez, 1987) , accounts for why it must be clari®ed whether or not Bcl-2 inhibited PARP activation was done so by aecting the DNA strand breaks. To resolve this issue, an alkaline unwinding method was employed to monitor the extent of DNA breakages in HL-60 vs HL-60-bcl-2 cells following GL331 treatment. According to Figure 7 , the DNA breakages increased proportionately with the time of GL331 exposure during the ®rst 30 min and reached a plateau at 60 min either in HL-60 or Bcl-2-overexpressing cells. The extent of DNA breakages between these two cells did not signi®cantly dier. Above ®ndings suggest that Bcl-2 do not protect cells from DNA damage elicited by GL331.
Discussion
Similar to VP-16, GL331 is a semisynthetic compound derived from a plant toxin podophyllotoxin. GL331, also a potent topoisomerase II inhibitor, shares many physico-chemical and biochemical properties with VP-16 (Wang et al., 1990) . GL331 showed ecacy in killing tumor cells which are resistant to VP-16 in vitro and in animal systems (Wang et al., 1990) . For example, the cytotoxicity of GL331 was approximately 40 times more potent than VP-16 to the adriamycinresistant p388 murine lymphoma cells. It was also found that the eux of GL331 in vincristine-resistant KB cells is signi®cantly lower than that of VP-16 (Wang et al., 1990) . Recently, GL331 was found to induce apoptosis in several types of cancer cell lines Overexpressing of Bcl-2 inhibits poly(ADP-ribosyl)ation of PARP. (a) Dierential induction of PARP activity by CPT, VP-16 and ADR in HL-60 vs HL-60-bcl-2 cells. Cells were treated with CPT(2 mM), ADR (5 mM) or VP-16 (1 mM) for 4 h, and activity gel assay was performed to measure the level of poly(ADP-ribosyl)ation of PARP, as described in Figure 4a . (b) U937 and U937-bcl-2 cells were treated with 4 mM GL331 for various times as indicated, and poly (ADP-ribosyl)ation of PARP was detected by activity gel analysis as described in Materials and methods . Several dierent mechanisms, including inhibition of protein tyrosine kinase, activation of protein tyrosine phosphatase , and premature activation of Cdc2 kinase (Huang et al., 1997) , are suggested to account for the cytotoxicity induced by GL331. In this study, we believe another novel mechanism of poly(ADPribosyl)ation of cellular proteins is critically involved in GL331-induced apoptosis. This conclusion is con®rmed by the ®ndings that GL331-induced DNA fragmentation, apoptotic morphology, and cellular viability are inhibited by PARP inhibitor, 3-AB. In corresponding to our ®ndings, many studies have demonstrated that either inhibiting PARP activity by 3-AB, or lowering intracellular substrate NAD + can protect cells from apoptosis induced by various treatments such as, adriamycin, cisplatin, VP-16, and UV irradiation (Gartenhaus et al., 1996) . Although the speci®city of 3-AB is of contention, several studies have con®rmed the preference of 3-AB in inhibiting the cellular PARP activity (Masutani et al., 1995) . However, here we also provide another direct evidence to show that speci®c blockage of the expression of PARP in cells by expressing antisense PARP could prevent GL331-induced DNA fragmentation. These observations suggest an indispensable role of PARP activation in GL331-induced cell death. An attempt is also made to overexpress PARP in various human and mouse cell types by transfection or infection with recombinant constructs. Under such measures, the human or mouse cDNAs are placed under the transcriptional control of diverse constitutive cellular or viral promoters, invariably resulting in cell death (Yoshihara et al., 1985) . Although only a few cellular contexts can be overexpressed for PARP, this overexpression would render cells more sensitive to girradiation ( Van et al., 1997) . However, these ®ndings are contradictory to other studies which showed that embryonic ®broblasts from PARP-knockout mice are still sensitive to apoptosis in response to various stresses including anti-Fas, tumor necrosis factor a, g- Figure 6 Inverse correlation between PARP activity and Bcl-2 protein in dierent Bcl-2-overexpressing clones. (a) Immunoblot analysis of alternative level of Bcl-2 protein in various independent Bcl-2-overexpressing clones such as, HL-60-bcl-2-1, HL-60-bcl-2-2, HL-60-bcl-2-3, HL-60-bcl-2-6 cells. (b) Cells were treated with (+) or without (7) 0.8 mM GL331, and followed by measurement of total intracellular PARP activity as described in the legend of Figure 1a . Each data represents the means of three independent experiments. Bars, means+s.e. (c) Flow cytometric analysis of hypodiploid cells in HL-60 and each Bcl-2-transfectant induced by 0.8 mM GL331. Cells were treated with 0.8 mM GL331 and harvested at indicated times for Flow cytometric analysis. The data is the representative of two reproducible experiments
Figure 7
Measurement of GL331-induced DNA strands breakage by Alkaline unwinding analysis. HL-60 and HL-60-bcl-2 cells were treated with 0.8 mM GL331 for various time, and percentage of single strand DNA was detected by alkaline unwinding method. Each data is the representative of two independent experiments irradiation, and dexamethasone . The discrepancy between our data and knockout experiments may be primarily due to dierent cell status; the former is cancerous cells and the latter is normal cells. Another possibility is that dierent apoptosis inducers may through distinct apoptotic mechanisms, i.e., PARP-dependent or -independent. Supportive of this concept, two studies (Endres et al., 1997; Eliasson et al., 1997) have demonstrated that PARP-knockout mice are resistant to peroxynitriteinduced ischemic injury via inhibiting apoptotic cell death.
Recent studies have demonstrated that during chemotherapy-or Fas-induced apoptosis, PARP is cleaved into a 25-kDa fragment containing the DNAbinding domain and a 85-kDa fragment containing the automodi®cation and catalytic domains (Shah et al., 1996) . In addition, this proteolytic cleavage decreases the activity of PARP and the 85-kDa fragment retains only basal PARP activity. The ICElike cysteine proteases are the executors for this PARP cleavage (Gu et al., 1995) . However, in this study, the apparent PARP cleavage during the course of apoptosis is not observed, suggesting that ICE-like cysteine protease is not involved in GL331-mediated cell death. More obviously, either the elevation of PARP activity (poly(ADP-ribosyl)ation) or the cleavage of PARP can independently occur in cells. Wright et al. (1996) recently demonstrated that NAD depletion-caused decrease in PARP activity renders HL-60 cells resistant to apoptosis by TNF-a or UV. A 24 kDa apoptotic serine protease (AP24), which acts downstream of PARP, can activate DNA fragmentation and apoptosis. This ®nding suggests that PARP activation signal is likely to directly or indirectly activate the apoptotic executors.
A reduced p53 induction response is found in cells de®cient in PARP synthesis. In addition, although exposing cells to VP-16 can increase p53 expression and subsequent apoptosis, it fails to signi®cantly increase p53 expression or apoptosis in PARPde®cient cells (Whitacre et al., 1995) .
Further evidence raised by Venkatachalam et al. (1997) con®rms that treating cells with PARP inhibitor, 3-AB, eectively attenuated the p53 accumulation by DNA damaging agent, thereby implying the contribution of PARP in stabilizing p53 levels. In general, increasing p53 expression promotes cells' ability to undergo apoptosis (Lopes et al., 1997) . However, in this study, the p53 gene is deleted in HL-60 cells. Thus, other alternative targets rather than p53 are likely aected by poly(ADPribosyl)ation and be involved in GL331-induced cell death process. Our ®ndings, while con®rming this assumption, indicate that GL331 induced an extensive ADP-ribosylation of histone H1 in HL-60 cells. The ADP-ribosylation of histone H1 has been implicated in facilitating the internucleosomal DNA fragmentation (Jacobson, 1997) . Conceivably, the change in polarity of the basic histone H1 by the association of highly negative poly(ADP-ribose) may reduce their anity to the associated DNA and, ultimately, aect the stability of chromatin structure. In this context, we recommend that inappropriate poly(ADP-ribosyl)ation of dierent intracellular proteins, i.e., histone H1 or p53, can serve as mediators for activating DNA nuclease and protease to execute the apoptotic process.
As demonstrated elsewhere, Bcl-2 has protected cells from apoptosis induced by a variety of DNAdamaging agents (Miyashita et al., 1993) . However, the biochemical action of Bcl-2 that exerts antiapoptotic eect against DNA-damaging agents remains unclear, in that no DNA repair systems have been shown to be associated with Bcl-2 function (Kluck et al., 1997) . Herein we present a novel mechanism by which Bcl-2 prevents DNA-damaging agents-induced apoptosis through attenuating the poly(ADP-ribosyl)ation activity in cells. According to our result, over-expression of Bcl-2 in HL-60 cells blocks the GL331-induced poly(ADP-ribosyl)ation of histone H1 and PARP itself and the subsequent apoptosis. Herein, the failure of PARP activation is reproducibly observed in another leukemic Bcl-2-overexpressing U937 cells when treating with GL331. Apparently Bcl-2 acts upstream of PARP and down-regulates this enzyme activity which is common for cells in response to GL331. Moreover, Bcl-2 overexpression can antagonize diverse types of anti-cancer drugs-induced PARP activity, indicating that Bcl-2 functions closely to PARP. In addition, analysing independent Bcl-2-overexpressing HL-60 clones reveals a strict inverse correlation emerging between the amounts of Bcl-2 and the level of basal PARP activity. This ®nding implicates that Bcl-2 down-regulates PARP activity through another mechanism rather than modulating the extent of DNA strand breaks. Data obtained from alkaline unwinding assay clearly reveal that no signi®cant dierence in DNA damages arises between control and Bcl-2-overexpressing cells following treatment with GL331.
Notably, the subcellular localization of Bcl-2 diers from that of PARP protein. Thus it seems unlikely that Bcl-2 directly interacts with PARP. Recently, Bcl-2, which was found to locate on the outer membrane of mitochondria, not only prevents the initiation of the cellular apoptotic program by stabilizing the mitochondrial permeability transition (PT), but also avoids the subsequent release of cytochrome C and AIF protease from mitochondria (Susin et al., 1997) . In addition to cytochrome C and AIF, PT pore also cause matrix Ca 2+ out¯ow (Sokolove and Haley, 1996) , depletes the reduced glutathione (Fabianek et al., 1997) , and alters the pyridine nucleotide pool (NADH 2 / NAD+NADPH 2 /NADP) (Takahashi et al., 1996) . In this respect, Bcl-2 likely inhibits PARP activity through modulating PT pore and prevents mitochondrial NAD out¯ow into nucleus. Nevertheless, a further investigation should clarify this working hypothesis.
Corresponding, we believe that optimally increasing PARP activity may facilitate the DNA repair enzyme to recover damaged DNA, in contrast, an inappropriate or substantial increase in PARP may serve as a signal and, ultimately, lead to cell death when DNA damages are serious and far from repair. Therefore, PARP may function as a`stress sensor' that trigger signals either to live or die, depending on DNA breaks. In sum, our ®ndings suggest that extensive poly(ADPribosyl)ation of nuclear targets is crucial for apoptotic cell death by the novel Topo II inhibitor, GL331. In addition, Bcl-2 acts after DNA-damaging events and functions upstream of PARP and inhibits the poly(ADP-ribosyl)ation signaling to prevent apoptosis (Figure 8 ).
Materials and methods
Cells and reagents
Cell lines used in this study were obtained from the American Type Culture Collection (Rockville, MD, USA), and were maintained in a humidi®ed 5% CO 2 atmosphere. HL-60 (human promyelocytic leukemia cell line). Also U937 cells were cultured in RPMI medium supplemented with 10% fetal calf serum, 2 mM Lglutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. GL331 was obtained from Genelabs Inc. VP-16, camptothecin, and doxorubicin were purchased from Sigma Chemical Co.
Establishment of bcl-2 transfectants
HL-60 and U937 cells overexpressing human Bcl-2 were created by electroporation (model T800; BTX, San Diego, CA, USA) of both cells with the bcl-2 expression vector, pC D j-bcl-2 (as kindly provided by Dr S-F Yang of the Institute of Molecular Biology, Academic Sinica, Taiwan) or control Neo vector. Developed by Tsujimotto et al. (1989) , pC D j-bcl-2, an expression vector that carries the human Bcl-2 cDNA under control of the SV40 promoter/enhancer sequence, was recently used in their study of drug resistance in ovarian cancer (Eliopoulos et al., 1995) . Brie¯y, cells were suspended in 1 ml Hepes-buered saline containing plasmid DNA and, then, underwent electroporation 350 V in amplitude and 99 ms in pulse width. Next, stable transfectants resistant to geneticin G418 (Gibco) were obtained. The levels of Bcl-2 expression in each clone were examined using Western blotting analysis.
Establishment of antisense-PARP transfectants
The parent PBSTR-1 retroviral vector was provided generously by Dr SA Reeves (Massachusetts General Hospital, Boston, MA, USA). It is a modi®ed version of the previously described Tet system (Paulus et al., 1996) . Brie¯y, the PBSTR-1 vector contains both components of the Tet system. The regulatory unit, containing the tetracycline-controlled transactivator (tTA) gene, is under the transcriptional control of internal SV40 promoter, and the response unit is under the transcriptional control of a minimal cytomegalovirus promoter, containing seven tet operators (tet O). The response unit is inserted into the vector in an antisense orientation relative to the regulatory unit. A multiple cloning site was inserted downstream of the response unit. The puromycin resistance gene is present under the transcriptional control of the 5' retroviral LTR. Human PARP cDNA (a generous gift from Prof Dr B Kaina at the Division of Applied Toxicology, Institute of Toxicology, University of Mainz, Mainz), was cloned into the multicloning site of the PBSTR-1 vector, at a BamHI site, in an antisense orientation, forming pTcPARPb.
Exponentially growing HL-60 cells were transfected with pTcPARPb by using electroporation with receiving four times electric treatment under following condition: electric amplitude, 700 V; pulse width, 99 ms. Transient transfectants were obtained after transfection for 24 h, and the levels of PARP expression in cells were con®rmed by¯ow cytometric analysis.
DNA gel electrophoresis
Cells were collected, washed twice with PBS and then Lysol in 100 ml lysis buer (50 mM Tris (pH 8.0), 10 mM EDTA, 0.5% sodium lauryl sarkosinate and 1 mg/ml proteinase K) for 3 h at 568C. Next, the cells were treated with 0.5 mg/ml RNase A for an additional 1 h at 568C. DNA was extracted with phenol/chloroform/isoamyl alcohol (25/24/1) before loading. DNA samples were loaded onto a 2% (w/v) agarose gel containing 0.1 mg/ ml ethidium bromide. The agarose gels were run for 90 min at 50 V in a TBE buer. Finally, the gels were observed and photographed under UV light.
Poly(ADP-ribose)polymerase activity assay
The procedure used to detect PARP activity was based on the procedure of Scovassi et al. (1984) . Protein samples were denatured in 65 mM Tris-HCl, pH 7.5, 0.1% SDS, and 33 mM DTT at 378C for 3 min and then subjected to 7.5% SDS-polyacrylamide gel electrophoresis containing 0.1 mg/ml activated calf thymus DNA. The gel was washed twice with 500 ml of the renaturation buer (50 mM Tris-HCl, pH 8.0, and 1.5 mM DTT) for 2 h and then incubated twice for 1 h at room temperature in 100 ml of renaturation buer containing 0.6 M guanidine HCl. After renaturation, the gel was washed at 48C with 500 ml of the renaturation buer (with ®ve changes over a 16-h period) and then incubated with 10 ml of the labeling buer (0.1 M Tris-HCl, pH 8.0, 10 mM MgCl 2 , 1 mM DTT, and 1 mM [ 32 P]NAD (50 mCi/ml) at 378C for 8 h. After extensive washing with 5% trichloroacetic acid (TCA) at room temperature over a period of 40 h, the gel was dried and subjected to autoradiography at 7808C.
Analysis of the poly(ADP-ribosyl)ation of histone H1
Cells were permeabilized for the poly(ADP-ribosyl)ation reaction as described earlier, and histone H1 was extracted by a modi®ed version of Cole's method (40). Brie¯y, perchloric acid was added to each cell sample in a 100-mm dish (5% ®nal concentration). After vortexing for 5 min and centrifugation at 10 000 r.p.m. for 5 min, the The novel topoismerase II inhibitor GL331 induces DNA strands breakage which initiates an inappropriate PARP activity and in turn causing an extensive poly(ADP-ribosyl)ation of nuclear proteins that eventually lead to cell death. However, Bcl-2 acts down-stream of DNA-damaging event and upstream of PARP, and inhibits poly(ADP-ribosyl)ation signaling that lead to apoptosis supernatant was saved and the pellet was re-extracted with 0.15 ml of 5% perchloric acid. Supernatant fractions were pooled and adjusted to 0.1 N HCl. Next, the supernatant fractions were mixed with four volumes of acetone and stirred for 16 h at 48C. The pellet of histone H1 was then collected by centrifugation at 12 000 g for 30 min and washed with acetone containing 0.1% HCl. Finally, poly(ADP-ribosyl)ation of histone H1 was analysed by 15% SDS ± PAGE and subsequent autoradiography.
Flow cytometry
Cells were collected, washed with ice-cold phosphatebuered saline (PBS), and ®xed in 70% ethanol at 7208C for at least 1 h. After ®xation, cells were washed twice, incubated in 0.5 ml of 0.5% Triton X-100/PBS for 30 min at 378C with 1 mg/ml of RNase A, and, ®nally, stained with 0.5 ml of 50 mg/ml propidium iodide for 10 min. Fluorescence emitted from the propidium iodide-DNA complex was quanti®ed after laser excitation of thē uorescent dye by using FACScan¯ow cytometry (Becton Dickinson).
Western blot analysis
Cells were lysed in a lysis buer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EGTA, 1% NP-40, 1 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl¯uoride, 1 mg/ml aprotinin and leupeptin, pH 7.4) for 20 min on ice. The lysates were centrifuged at 14 500 r.p.m. for 20 min at 48C, and, then, protein concentrations were determined by using a commercial BCA kit (PIERCES Co.). A 50 mg sample of each lysate was subjected to a 12% SDS-polyacrylamide gel electrophoresis. Finally, proteins were then transferred to nitrocellulose paper and immunoblotted with anti-Bcl-2, or PARP antibodies (Santa Cruz Biotechnology). Detection was performed using the ECL (Amersham).
Determination of single strand breaks (SSBs) in DNA
The number of SSBs was determined using the alkaline unwinding technique described by Solveing Walles and Erixon (Solveig et al., 1984) . Brie¯y, cells (1610 6 ) were washed with PBS and digested with 16trypsin-EDTA, then treated with 30 mM NaOH, 0.15 M NaCl at room temperature for 10 min in the dark. The alkaline unwinding was terminated by adding the neutralizing solution (0.02 M NaH 2 PO 4 ) to PH 6.8. The solution was treated with a brief ultrasonication (40 W, 15 s) before adding SDS to a ®nal concentration of 0.25 g/100 ml. The sample could be stored deep-frozen or be put on glass columns of hydroxylapatite (106150 mm; Bio-Gel HTP; DNA-grade Bio-Gel=2 : 1; Bio-Rad; 0.3 g per column) at 608C. The column was washed with 10 ml 0.02 M NaH 2 PO 4 (PH 6.8). Next, the single and double strand DNA were eluted with 5 ml 0.08 M and 0.25 M KH 2 PO 4 (PH 6.8) respectively. DAPI was added and the amount of DNA was measured by¯uorimetry under an excitation wavelength of 373 nm; the absorbance of emission (Ab) was detected at 454 nm. The number of SSBs was re¯ected in the percentage of single-strand DNA calculated from the following equation:
Ab 454nm of single strand DNA Ab 454nm of single strand DNA double strand DNA Â100
